Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | PTGER4 | P35408 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ELANE | P08246 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | GABRP | O00591 | 1/20 | 0.36 |
| ▸ | GABRD | O14764 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.36 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.36 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.36 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL51657 | 0.85 | ALDH1A1 (0.50) | SLC2A1MAPTL3MBTL1NPSR1ALDH1A1 | |
| SCHEMBL29366895 | 0.85 | ALDH1A1 (0.50) | SLC2A1MAPTL3MBTL1NPSR1ALDH1A1 | |
| SCHEMBL29366898 | 0.82 | RAB9A (0.41) | SLC2A1MAPTL3MBTL1ALDH1A1KDM4E | |
| SCHEMBL756340 | 0.82 | RAB9A (0.41) | SLC2A1MAPTL3MBTL1ALDH1A1KDM4E | |
| SCHEMBL29366197 | 0.81 | KIF11 (0.47) | SLC2A1MAPTL3MBTL1ALDH1A1KDM4E | |
| SCHEMBL29895747 | 0.81 | KIF11 (0.47) | SLC2A1MAPTL3MBTL1ALDH1A1KDM4E | |
| SCHEMBL599926 | 0.81 | KIF11 (0.47) | SLC2A1MAPTL3MBTL1ALDH1A1KDM4E | |
| SCHEMBL29779703 | 0.79 | SLC2A1 (0.50) | SLC2A1MAPTL3MBTL1NPSR1ALDH1A1 | |
| SCHEMBL19809195 | 0.79 | SLC2A1 (0.50) | SLC2A1MAPTL3MBTL1NPSR1ALDH1A1 | |
| SCHEMBL2227910 | 0.78 | PTGER4 (0.45) | SLC2A1MAPTL3MBTL1ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9229136-B2 | Microlens array unit and image processing apparatus | TOSHIBA TEC KABUSHIKI KAISHA (JP) | 2016-01-05 | — | — | US | disclosed |
| US-20140084141-A1 | LIGHT BLOCKING INK, MICROLENS ARRAY UNIT, IMAGE PROCESSING APPARATUS | TOSHIBA TEC KABUSHIKI KAISHA (JP) | 2014-03-27 | — | — | US | disclosed |
| EP-1574493-B1 | PROCESS FOR PRODUCING ANTHRACENE DIETHER | KAWASAKI KASEI CHEMICALS (JP) | 2013-06-19 | — | — | EP | disclosed |
| CN-100347255-C | Inkjet ink, printed matter, and inkjet recording method | TOSHIBA TEC KK (JP) | 2007-11-07 | — | — | CN | disclosed |
| US-7279607-B2 | Process for producing anthracene diether | KAWASAKI KASEI CHEMICALS LTD. (JP) | 2007-10-09 | — | — | US | disclosed |
| US-20060079721-A1 | Process for producing anthracene diether | HIROYUKI HONDA ET EL | 2006-04-13 | — | — | US | disclosed |
| US-20060023043-A1 | Inkjet ink, printed matters, and inkjet recording method | TOSHIBA TEC KABUSHIKI KAISHA (JP) | 2006-02-02 | — | — | US | disclosed |
| EP-1621593-A1 | Inkjet ink, printed matters, and inkjet recording method | Toshiba Tec Kabushiki Kaisha (JP) | 2006-02-01 | — | — | EP | disclosed |
| CN-1727418-A | Inkjet ink, printed matter, and inkjet recording method | TOSHIBA TEC KK (JP) | 2006-02-01 | — | — | CN | disclosed |
| EP-1574493-A1 | PROCESS FOR PRODUCING ANTHRACENE DIETHER | Kawasaki Kasei Chemicals Ltd. (JP) | 2005-09-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060079721-A1 | Process for producing anthracene diether | DOHH, DHCR7, HSD17B11 | SLC2A1 4353/4885MAPT 2952/4885L3MBTL1 4846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.